GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Nexus Surgical And Medicare Ltd

Nexus Surgical & Medicare Q2 FY27 Net Profit Rs. 17.01 lakhs, Sales Rs. 370.87 lakhs

RESULTS ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 14 Nov 2026, 05:25 PM IST  ·  BSE ID: 8d9fb88c-efaa-4062-a490-39630687fba1
View Original BSE Filing (PDF)
💡
In Simple Terms
The company announced its latest financial results, showing a net profit of Rs. 17.01 lakhs and sales of Rs. 370.87 lakhs for the recent quarter.
🤖 AI Summary
  • Nexus Surgical and Medicare reported Q2 FY27 net profit of Rs. 17.01 lakhs for the quarter ended September 30, 2026.
  • Sales and services for Q2 FY27 stood at Rs. 370.87 lakhs, as per the unaudited financial results.
  • Half year ended September 30, 2026, saw net profit of Rs. 37.43 lakhs and sales of Rs. 625.67 lakhs.
  • The Board of Directors approved the unaudited results on November 14, 2026, following audit committee review.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Sales and Services (Q2 FY27)
370.87 Rs. in lakh
218.15%
Profit for the period (Q2 FY27)
17.01 Rs. in lakh
-2.07%
Sales and Services (Half Year Sep 30, 2026)
625.67 Rs. in lakh
116.41%
Profit for the period (Half Year Sep 30, 2026)
37.43 Rs. in lakh
14.77%
Total Assets (Sep 30, 2026)
381.93 Rs. in lakhs
Cash and cash equivalents (Sep 30, 2026)
15.58 Rs. in lakhs
🏢 How This Affects the Company
📈
Business Impact
The company's sales and services grew to Rs. 370.87 lakhs in Q2 FY27 from Rs. 116.58 lakhs in Q2 FY26, indicating an increase in business activity.
💰
Financial Impact
Net profit for Q2 FY27 was Rs. 17.01 lakhs, contributing to a half-year net profit of Rs. 37.43 lakhs. Cash and cash equivalents decreased from Rs. 50.44 lakhs as of March 31, 2026, to Rs. 15.58 lakhs as of September 30, 2026.
⚙️
Operational Impact
Operating expenses, excluding purchase of stock-in-trade and change in inventories, increased, with other expenses reaching Rs. 279.58 lakhs in Q2 FY27 compared to Rs. 21.52 lakhs in Q2 FY26.
⚠️
Risk Impact
Net cash generated from operating activities for the half year ended September 30, 2026, was Rs. 10.34 lakhs, an improvement from a negative Rs. 16.46 lakhs in the prior half year.
👥 What This Means For Shareholders
✅
Action Required
No specific action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, as reflected by the net profit of Rs. 17.01 lakhs for Q2 FY27 and Rs. 37.43 lakhs for the half year.
🔍
Management Signal
The Board's approval of the unaudited financial results signals the company's regular compliance and reporting practices, indicating continuity in financial disclosure.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — assess sales trajectory and expense management.
Next board meeting outcome — check for strategic decisions or operational updates.
Annual financial results for FY27 — evaluate full-year performance and audited figures.
MEDIUM RISK Significant increase in other expenses needs careful monitoring for its impact on long-term profitability and efficiency.
💡 Investor Takeaway
Nexus Surgical and Medicare reported Q2 FY27 net profit of Rs. 17.01 lakhs and sales of Rs. 370.87 lakhs. Half-year net profit was Rs. 37.43 lakhs on sales of Rs. 625.67 lakhs. Sales show growth, but other expenses have substantially increased year-on-year.
⚖️ Strengths & Concerns

✅ Positives

  • Sales and Services for Q2 FY27 increased to Rs. 370.87 lakhs from Rs. 116.58 lakhs in Q2 FY26, demonstrating revenue growth.
  • Net cash generated from operating activities for the half year ended September 30, 2026, improved to Rs. 10.34 lakhs from a negative Rs. 16.46 lakhs in the prior year.

⚠️ Concerns

  • Other expenses significantly increased to Rs. 279.58 lakhs in Q2 FY27 compared to Rs. 21.52 lakhs in Q2 FY26, impacting profitability.
  • Cash and cash equivalents decreased from Rs. 50.44 lakhs as of March 31, 2026, to Rs. 15.58 lakhs as of September 30, 2026.
📅 Company Track Record
In a prior filing on May 28, 2026, Nexus Surgical And Medicare Ltd reported a net profit of Rs. 73.61 lakhs and sales of Rs. 786.81 lakhs for the full FY26. This context allows for comparison of current half-year performance against previous full-year figures.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Nexus Surgical And Medicare Ltd's net profit for Q2 FY27?
Nexus Surgical And Medicare Ltd reported a net profit of Rs. 17.01 lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What were the sales and services for Nexus Surgical And Medicare Ltd in Q2 FY27?
Sales and services for Nexus Surgical And Medicare Ltd in Q2 FY27 (quarter ended September 30, 2026) amounted to Rs. 370.87 lakhs.
How did Nexus Surgical And Medicare Ltd perform for the half year ended September 30, 2026?
For the half year ended September 30, 2026, Nexus Surgical And Medicare Ltd recorded a net profit of Rs. 37.43 lakhs and sales and services of Rs. 625.67 lakhs.
What was the company's cash and cash equivalents balance as of September 30, 2026?
As of September 30, 2026, Nexus Surgical And Medicare Ltd had cash and cash equivalents of Rs. 15.58 lakhs.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.

Live IPO, GMP and market updates on Telegram

IPO open and close dates, grey market premium moves, subscription figures, allotment and listing days, and the market updates worth knowing about, posted on the channel as they happen.

Join the channel